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Editorial
Beyond Culprit Vessel Recanalization in Myocardial 
Infarction with ST-Segment Elevation
Anibal P. Abelin1, Alexandre Quadros2
T he main objective of primary percutaneous coronary intervention (PCI) is to re-establish the patency of the infarct-related artery and to obtain reperfusion 
at the microvascular level as soon as possible after the 
onset of symptoms.1 The angiographic assessment of 
myocardial blood flow is assessed by the Thrombolysis 
in Myocardial Infarction (TIMI) flow criteria, but up to 
half of patients with TIMI 3 flow after primary PCI do 
not achieve reperfusion at the microvascular level.2,3 A 
useful, simple, and inexpensive tool to assess microvas-
cular reperfusion is the analysis of ST-segment resolution 
on the electrocardiogram (ECG) after reperfusion therapy 
in patients with ST-segment elevation myocardial infarc-
tion (STEMI), as recommended by the North American, 
European, and Brazilian guidelines.4-9 Initially used to 
assess reperfusion after thrombolysis and to guide the 
rescue PCI, the analysis of ST-segment resolution helps 
to reclassify the risk of the patient, especially in those 
with TIMI 3 flow after primary PCI.4,6,10-12
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In this issue, Andrade et al.13 evaluated 61 patients 
who underwent primary PCI between March 2012 and 
July 2013, comparing their clinical and angiographic 
characteristics in relation to the resolution of the ST-
segment, which occurred in one third of cases. The group 
of patients without ST-segment resolution showed higher 
heart rate, prevalence of diabetes mellitus, and chronic 
renal failure, and a tendency to longer ischemic time; 
mortality was also higher in these patients. Although 
the small number of patients prevented a more robust 
multivariate analysis, this is an important initiative in 
the search of a more elaborate result of a borrowed, 
easy to obtain and inexpensive outcome, indicating 
that similar trials are rare in our country.
The analysis of ST-segment resolution is performed 
by comparing the ECG performed between 60 and 90 
minutes after reperfusion therapy and the baseline ECG, 
obtained at the time of STEMI diagnosis. Analysis by 
calculating the sum of ST-segment elevations in leads 
related to infarction and the analysis by the resolution 
of the lead with greater ST-segment elevation, as de-
scribed below, are the methodologies most often cited 
in the literature:14,15
– sum of ST-segment elevation: the elevation of the 
ST-segment is measured at the J-point (20 ms after the 
ST-segment), and the sum is performed according to 
the location of STEMI. For an anterior wall myocardial 
infarction, the ST-segment elevations in leads V1 to V6, 
I, and aVL are added. For an inferior wall infarction, 
the ST-segment elevations in leads II, III, aVF, V5, and 
V6 are added. The resolution rate of the sum of ST-
segment elevations from baseline ECG, compared to 
post-reperfusion ECG, can be analyzed in two or three 
categories; 50% is the cut-off point for two categories 
(full resolution, ≥ 50 %; and no resolution, <  50%), 
and 70% is the cut-off point for three categories (full 
resolution, ≥  70%; partial resolution, 30% to <  70%; 
and absence of resolution, <  30%),5,14
– resolution of the ST-segment in the lead with 
higher elevation: calculated from the percentage of 
reduction in the elevation of the ST-segment from the 
baseline ECG, compared to post-reperfusion ECG, at 
the lead with the largest baseline ST-segment eleva-
tion. The resolution is analyzed in two (full resolution, 
≥  50%; and no resolution <  50%) or three categories 
(full resolution, ≥ 70%; partial resolution, 30 to < 70%; 
and no resolution, <  30%).15
Recently, Buller et al.11 prospectively compared six 
methods to calculate the ST-segment resolution in a cohort 
of 4,866 patients undergoing primary PCI. Among the 
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tested methods, the isolated analysis of the lead with 
higher residual ST-segment elevation in post-PCI ECG 
showed prognostic ability at least equivalent to more 
complex methodologies. Furthermore, this methodology 
eliminates the analysis of basal ECG. Patients with re-
sidual ST-segment elevation ≥ 2 mm showed higher risk 
of cardiovascular events after 90 days, while patients 
with 1 to <  2 mm had an intermediate risk of events. 
The finding of a residual ST-segment elevation < 1 mm 
identified patients at low risk of events, regardless of 
the TIMI flow after primary PCI.
In short, the analysis of ST-segment resolution is 
an important prognostic indicator in the era of modern 
primary PCI, and is an important research tool in the 
evaluation of the outcome of these procedures. In daily 
clinical practice, this analysis has often been underused, 
probably due to lack of evidence-based interventions 
that can be adopted in patients with partial ST-segment 
resolution. New therapeutic modalities aimed at limiting 
the infarct extension, decreasing the reperfusion injury, 
and minimising the deleterious effects of distal micro-
embolism, diffuse spasm, and inflammation remain as 
important goals to be pursued in patients undergoing 
primary PCI.
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